Imanol Peña

731 total citations
8 papers, 180 citations indexed

About

Imanol Peña is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Imanol Peña has authored 8 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in Molecular Biology. Recurrent topics in Imanol Peña's work include Trypanosoma species research and implications (6 papers), Research on Leishmaniasis Studies (5 papers) and Biochemical and Molecular Research (1 paper). Imanol Peña is often cited by papers focused on Trypanosoma species research and implications (6 papers), Research on Leishmaniasis Studies (5 papers) and Biochemical and Molecular Research (1 paper). Imanol Peña collaborates with scholars based in Spain, United Kingdom and Argentina. Imanol Peña's co-authors include Juan Cantizani, Julio Martín, J.J. Martin, Ana I. Bardera, Julio Alonso-Padilla, Ignacio Cotillo, Juan Manuel Domı́nguez, Ana Rodrı́guez, Fernando Aguilar and Rosario Díaz-González and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and PLoS neglected tropical diseases.

In The Last Decade

Imanol Peña

8 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Imanol Peña Spain 6 140 128 45 43 24 8 180
Graciela Diap Switzerland 6 167 1.2× 119 0.9× 42 0.9× 20 0.5× 38 1.6× 7 234
Ignacio Cotillo Spain 7 141 1.0× 153 1.2× 110 2.4× 39 0.9× 18 0.8× 10 225
Lorna Campbell United Kingdom 4 129 0.9× 117 0.9× 67 1.5× 27 0.6× 16 0.7× 4 167
Laura Maria Alcântara Brazil 10 199 1.4× 143 1.1× 114 2.5× 71 1.7× 28 1.2× 13 305
Maria Osuna‐Cabello United Kingdom 6 152 1.1× 160 1.3× 103 2.3× 45 1.0× 20 0.8× 6 224
Marzuq A. Ungogo United Kingdom 10 97 0.7× 126 1.0× 35 0.8× 64 1.5× 18 0.8× 24 238
Luke Mercer Switzerland 5 74 0.5× 86 0.7× 48 1.1× 45 1.0× 16 0.7× 5 160
Ana I. Bardera Spain 6 102 0.7× 49 0.4× 30 0.7× 40 0.9× 14 0.6× 6 163
İbrahim Çavuş Türkiye 10 213 1.5× 86 0.7× 46 1.0× 15 0.3× 25 1.0× 47 263
Melisa Sayé Argentina 10 123 0.9× 187 1.5× 108 2.4× 132 3.1× 22 0.9× 28 286

Countries citing papers authored by Imanol Peña

Since Specialization
Citations

This map shows the geographic impact of Imanol Peña's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imanol Peña with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imanol Peña more than expected).

Fields of papers citing papers by Imanol Peña

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imanol Peña. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imanol Peña. The network helps show where Imanol Peña may publish in the future.

Co-authorship network of co-authors of Imanol Peña

This figure shows the co-authorship network connecting the top 25 collaborators of Imanol Peña. A scholar is included among the top collaborators of Imanol Peña based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imanol Peña. Imanol Peña is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Alonso, Victoria Lucía, Imanol Peña, Juan Cantizani, et al.. (2024). Identification of novel bromodomain inhibitors of Trypanosoma cruzi bromodomain factor 2 ( Tc BDF2) using a fluorescence polarization-based high-throughput assay. Antimicrobial Agents and Chemotherapy. 68(8). e0024324–e0024324. 2 indexed citations
2.
Armitage, Emily G., Joanna Godzień, Imanol Peña, et al.. (2018). Metabolic Clustering Analysis as a Strategy for Compound Selection in the Drug Discovery Pipeline for Leishmaniasis. ACS Chemical Biology. 13(5). 1361–1369. 13 indexed citations
3.
Armitage, Emily G., Joanna Godzień, Imanol Peña, et al.. (2018). Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine. Antimicrobial Agents and Chemotherapy. 62(5). 36 indexed citations
4.
Cantizani, Juan, Imanol Peña, Pilar Manzano, et al.. (2018). Importance of secondary screening with clinical isolates for anti-leishmania drug discovery. Scientific Reports. 8(1). 11765–11765. 20 indexed citations
5.
Cantizani, Juan, et al.. (2017). Unravelling the rate of action of hits in the Leishmania donovani box using standard drugs amphotericin B and miltefosine. PLoS neglected tropical diseases. 11(5). e0005629–e0005629. 3 indexed citations
6.
Díaz-González, Rosario, Fernando Aguilar, Imanol Peña, et al.. (2016). A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani. Antimicrobial Agents and Chemotherapy. 60(6). 3524–3532. 45 indexed citations
7.
Alonso-Padilla, Julio, Ignacio Cotillo, Juan Cantizani, et al.. (2015). Automated High-Content Assay for Compounds Selectively Toxic to Trypanosoma cruzi in a Myoblastic Cell Line. PLoS neglected tropical diseases. 9(1). e0003493–e0003493. 49 indexed citations
8.
Peña, Imanol & Juan Manuel Domı́nguez. (2010). Thermally Denatured BSA, a Surrogate Additive to Replace BSA in Buffers for High-Throughput Screening. SLAS DISCOVERY. 15(10). 1281–1286. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Graciela Diap Breakdown of academic impact, for papers by Ignacio Cotillo Breakdown of academic impact, for papers by Lorna Campbell Breakdown of academic impact, for papers by Laura Maria Alcântara Breakdown of academic impact, for papers by Maria Osuna‐Cabello Breakdown of academic impact, for papers by Marzuq A. Ungogo Breakdown of academic impact, for papers by Luke Mercer Breakdown of academic impact, for papers by Ana I. Bardera Breakdown of academic impact, for papers by İbrahim Çavuş Breakdown of academic impact, for papers by Melisa Sayé
Rankless by CCL
2026